Delivery Order SPE2DB22D1202-SPE2DB24FUPS4
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $37K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $15,883.20 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has been awarded numerous pharmaceutical and medical supply contracts by DLA to support military...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $31,766.40 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will deliver the pharmaceutical items to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,792.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This award is under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to deliver...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,416,115 units of the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. The $4,922.76 delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has previously received numerous...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML vaccines. The contract has a ceiling value of $4,885.04 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the supply of the vaccine product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $5,189.16 firm-fixed-price contract has a completion date of June 4, 2024. Amerisourcebergen, through its Corporate Office division, has extensive experience providing a wide range of pharmaceutical products and medical supplies to the Department of Defense and other...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. The firm fixed price contract has a ceiling value of $10,256.38 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous DLA...
- This federal contract award, valued at $11,076.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of 0.5 mL syringes of the VAXNEUVANCE vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of December 3, 2024. Amerisourcebergen, a for-profit organization, is registered in the System for Award Management (SAM.gov) and has established itself as...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 0.5 ML VAXNEUVANCE syringes. The $1,317.00 award has a completion date of February 20, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB20D2014|SPE2DB24FB28J) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,840.23 award has an ultimate completion date of March 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025 to deliver a wide range of pharmaceutical products and...